Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Fornacon-Wood

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2026
Environmental determinants of cancer outcomes: a scoping reviewAzadeh Abravan, Isabella Fornacon-Wood, Richard Kingston, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2020
Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hypeIsabella Fornacon-Wood, Corinne Faivre-Finn, James P B O'Connor, et al.
International Journal of Radiation Oncology, Biology, Physics|December 16, 2022
In Reply to Chowdhry et alIsabella Fornacon-Wood, Hitesh Mistry, Gareth J Price, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 3, 2022
Bayesian methods provide a practical real-world evidence framework for evaluating the impact of changes in radiotherapyIsabella Fornacon-Wood, Hitesh Mistry, Corinne Johnson-Hart, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2022
Understanding the Differences Between Bayesian and Frequentist StatisticsIsabella Fornacon-Wood, Hitesh Mistry, Corinne Johnson-Hart, et al.
The British Journal of Radiology|March 18, 2025
Mastering CT-based radiomic research in lung cancer: a practical guide from study design to critical appraisalAshley Horne, Azadeh Abravan, Isabella Fornacon-Wood, et al.
Frontiers in Oncology|April 25, 2024
A study demonstrating users' preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE<sup>®</sup> in patients with lung cancerThomas Jordan, Thitikorn Nuamek, Isabella Fornacon-Wood, et al.
European Radiology|June 3, 2020
Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platformIsabella Fornacon-Wood, Hitesh Mistry, Christoph J Ackermann, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2024
Analyzing Patient-Reported Outcome Data in Oncology CareIsabella Fornacon-Wood, Thitikorn Nuamek, Eleanor M Hudson, et al.
BMJ Open|August 27, 2025
Developing a prospective rapid-learning methodology to evaluate the survival impact of changing radiotherapy practice to include a new heart dose limit for patients with lung cancer in a UK specialist cancer centre (RAPID-RT): a protocolIsabella Fornacon-Wood, Rebecca Holley, Harry Crawford, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2026
Environmental determinants of cancer outcomes: a scoping reviewAzadeh Abravan, Isabella Fornacon-Wood, Richard Kingston, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2020
Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hypeIsabella Fornacon-Wood, Corinne Faivre-Finn, James P B O'Connor, et al.
International Journal of Radiation Oncology, Biology, Physics|December 16, 2022
In Reply to Chowdhry et alIsabella Fornacon-Wood, Hitesh Mistry, Gareth J Price, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 3, 2022
Bayesian methods provide a practical real-world evidence framework for evaluating the impact of changes in radiotherapyIsabella Fornacon-Wood, Hitesh Mistry, Corinne Johnson-Hart, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2022
Understanding the Differences Between Bayesian and Frequentist StatisticsIsabella Fornacon-Wood, Hitesh Mistry, Corinne Johnson-Hart, et al.
The British Journal of Radiology|March 18, 2025
Mastering CT-based radiomic research in lung cancer: a practical guide from study design to critical appraisalAshley Horne, Azadeh Abravan, Isabella Fornacon-Wood, et al.
Frontiers in Oncology|April 25, 2024
A study demonstrating users' preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE<sup>®</sup> in patients with lung cancerThomas Jordan, Thitikorn Nuamek, Isabella Fornacon-Wood, et al.
European Radiology|June 3, 2020
Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platformIsabella Fornacon-Wood, Hitesh Mistry, Christoph J Ackermann, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2024
Analyzing Patient-Reported Outcome Data in Oncology CareIsabella Fornacon-Wood, Thitikorn Nuamek, Eleanor M Hudson, et al.
BMJ Open|August 27, 2025
Developing a prospective rapid-learning methodology to evaluate the survival impact of changing radiotherapy practice to include a new heart dose limit for patients with lung cancer in a UK specialist cancer centre (RAPID-RT): a protocolIsabella Fornacon-Wood, Rebecca Holley, Harry Crawford, et al.
Pageof 2